Sabby Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-2,415
Closed -$25.2M 367
2016
Q3
$25.2M Buy
2,415
+2,338
+3,036% +$253K 0.95% 20
2016
Q2
$759K Buy
+77
New +$7.96K 0.04% 187
2015
Q2
Sell
-478
Closed -$5.51M 402
2015
Q1
$5.51M Buy
478
+408
+583% +$48.8K 0.23% 69
2014
Q4
$783 Sell
70
-2,678
-97% -$282K 0.02% 170
2014
Q3
$26K Sell
2,748
-378
-12% -$34.1K 1% 19
2014
Q2
$26.8M Sell
3,126
-962
-24% -$73.2K 1.15% 17
2014
Q1
$28.5M Buy
4,088
+2,792
+215% +$221K 1.6% 17
2013
Q4
$10.9M Sell
1,296
-1,060
-45% -$83.9K 0.7% 32
2013
Q3
$18.1M Buy
2,356
+1,208
+105% +$84.7K 1.18% 24
2013
Q2
$6.71M Buy
+1,148
New +$69.1K 0.45% 51

Other funds holding CELG

Sabby Management's CELG Position: Q4 2016 in Review

Sabby Management sold out of Celgene Corp (CELG) in Q4 2016, closing a stake of 37,728 shares — an estimated $3.94M sold.

Sabby Management first reported a position in CELG in Q1 2014 and held it in 3 quarters. The position peaked at $3.94M in Q3 2016. 1,375 funds tracked by Wall St. Rank hold CELG as of Q4 2016.

  • Sabby Management reported no remaining Celgene Corp position as of Q4 2016 after selling out during the quarter.
  • Sabby Management sold 37,728 Celgene Corp shares in Q4 2016, an estimated $3.94M.
  • Sabby Management first reported a position in Celgene Corp in Q1 2014 and held it in 3 quarters.
  • Sabby Management's Celgene Corp position peaked at $3.94M in Q3 2016.
  • 1,375 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2016.

Based on Sabby Management's 13F filing for Q4 2016, filed 14 Feb 2017.